Rocket Lab’s Two-Speed Reality: A $266 Million Defense Win Versus a 58% Stock Wipeout
Published on 07/27/2026 at 17:32 | Redaktion boerse-global.de
Rocket Lab is living a split-screen existence right now. On one side, the company just locked in the largest launch services contract in its history — a $266 million deal with the US Space Force. On the other, its stock has shed nearly 58 percent from the May peak of €133.80, closing Friday at €56.40 after an 8.29 percent single-day rout. The disconnect between operational momentum and market punishment has rarely been starker.
The Space Force award, announced in July, tasks Rocket Lab with flying a dozen suborbital missions under the Rocket Systems Launch Program, with an option for six more. These aren’t routine satellite deliveries. The flights are designed for missile defense testing — a high-barrier segment where reliability and rapid response matter more than payload capacity. Most launches will originate from a new facility at the Pacific Spaceport Complex in Kodiak, Alaska, with the first missions expected no earlier than late 2026.
Geographic diversification away from Rocket Lab’s traditional launch sites is one takeaway. The bigger one: the company is now embedded in the Pentagon’s missile defense architecture. Its HASTE rocket fills a niche that legacy aerospace primes have largely ignored — fast-turnaround, high-cadence test launches for defense agencies. CEO Peter Beck has framed the company’s edge as “cadence, iteration and consistent execution,” language that maps directly onto what the Space Force demands from its test partners.
Neutron Anxiety Overwhelms the Headlines
Yet the stock’s slide tells a different story. The 30-day loss stands at roughly 24 percent, and the annualized volatility over that period has hit a punishing 88 percent. The 14-day relative strength index sits at 30.8 — deep in oversold territory — while the share price has fallen more than 16 percent below its 200-day moving average of €67.36. Those technical readings typically flag a consolidation or a mean-reversion bounce, not a structural breakdown.
Should investors sell immediately? Or is it worth buying Rocket Lab?
So why the selloff? The answer centers on Neutron, Rocket Lab’s next-generation medium-lift rocket. The company officially targets a first flight in the fourth quarter of 2026, but rumors of delays in engine certification and key test milestones have spooked investors. Beck has repeatedly pointed to the transition from component production to full assembly on the test stand as the decisive progress marker. With the stock trading at a premium valuation that hinges on Neutron’s on-time delivery, any whisper of slippage triggers an outsized reaction.
The market’s sensitivity is understandable. Rocket Lab is morphing from a small-launch specialist into a vertically integrated space systems provider, but that transformation won’t be complete until Neutron flies. Until then, the stock is pricing in execution risk that no amount of defense contract wins can fully offset.
A Backlog That’s Doubled in Six Months
The operational picture, however, keeps improving. The Space Force deal pushes Rocket Lab’s total backlog to roughly $2.2 billion — up from around $1.42 billion at the start of the year. That’s a 55 percent increase in six months, driven almost entirely by government contracts that carry higher margins and longer revenue visibility than commercial launches.
The VICTUS-HAZE mission, also completed in July, underscored the company’s tactical value to the Pentagon. Rocket Lab launched an Electron rocket just 16 hours and 42 minutes after receiving the go order, setting an industry record for rapid-response space operations. That kind of agility is precisely what the Space Force is buying with the new $266 million contract.
Over a 12-month horizon, Rocket Lab’s stock is still up 46 percent, a reminder that the current weakness may be a consolidation within a longer uptrend rather than a trend reversal. The market capitalization stands at €44.36 billion — a hefty multiple for a company that generated a fraction of that in revenue last year, but one that reflects the strategic premium investors assign to defense-linked space assets.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
What the August Earnings Call Could Settle
The next major catalyst arrives on August 10, when Rocket Lab reports second-quarter results after the US close. The earnings call is expected to provide concrete updates on Neutron’s production status, including whether the engine certification timeline remains intact. Investors will also be watching for integration progress on recent acquisitions, which are central to Beck’s vertical integration strategy.
Analysts see a significant gap between the current price and fair value. The average price target stands at €100.51, implying roughly 76 percent upside from Friday’s close. Whether that gap closes depends heavily on how cleanly the first Alaska launches go and whether Neutron stays on schedule. If Rocket Lab can maintain its launch cadence while deepening its defense footprint, the narrative shift from commercial disruptor to national security partner may finally pull the stock along with it.
Ad
Rocket Lab Stock: New Analysis - 27 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
